Company / Gross Profit
STAAR Surgical Company Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$182.4M
FY2025
5-year range
$112.0M / $252.7M
FY2021-FY2025
Trend
-23.9%
vs FY2024
Sector context
#79 of 100
Health Care
What the data says
STAAR Surgical Company's gross profit of $182M is lower than 79% of companies in the Health Care sector (FY2025). Gross Profit has fluctuated over the past 10 years, ranging from $53M in FY2017 to $253M in FY2023.
Based on SEC 10-K filings.
$182M in FY2025 with a 5-year CAGR of +14.8%.
Declined from $253M to $182M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -6.5%
- 5-Year CAGR
- +14.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 100This company $182.4M Sector average $1.8B
▼
-90.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.8%, indicating consistent growth.
- In FY2025, gross profit decreased 23.9% year-over-year.
- Ranks #79 out of 100 companies in the Health Care sector.
- Peak gross profit was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $182.4M | -23.9% |
| FY2024 | $239.6M | -5.2% |
| FY2023 | $252.7M | +13.1% |
| FY2022 | $223.4M | +99.5% |
| FY2021 | $112.0M | +22.3% |
| FY2020 | $91.5M | -18.3% |
| FY2019 | $112.0M | +91.8% |
| FY2018 | $58.4M | +10.7% |
| FY2017 | $52.7M | -9.7% |
| FY2016 | $58.4M | +10.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026